Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study

BACKGROUND: Venous thromboembolism is a common complication of cancer and its treatments. Treatment of cancer-associated thrombosis (CAT) differs from treatment of thrombosis in noncancer patients, requiring a daily injection of low-molecular-weight heparin (LMWH) for 6 months instead of an oral ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Seaman, Siwan, Nelson, Annmarie, Noble, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986276/
https://www.ncbi.nlm.nih.gov/pubmed/24748774
http://dx.doi.org/10.2147/PPA.S58595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986276/
https://www.ncbi.nlm.nih.gov/pubmed/24748774
http://dx.doi.org/10.2147/PPA.S58595

Ejemplares similares